Erectile disorder: How science is moving beyond Viagra
medicalxpress - Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond physical functioning, erecti…
AI Summary: Researchers are advancing alternatives to sildenafil-era approaches for erectile disorder, exploring new biological targets and therapies that aim to restore function rather than just patch symptoms. The coverage explains emerging mechanisms, investigational treatments and the shifting clinical landscape—because sometimes a Band-Aid on performance isn’t the long-term plan.
Related Stories
Mid‑stage Parkinson trial failure halts drug development plans / 7 wks
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 2 months
First-in-human trial primes immune system to accept donor livers / 2 months
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 2 months
Keratin 16 restrains skin inflammation and may guide treatments / 3 months
Avalyn upsizes IPO to raise cash for lung drug trials / 2 months
Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 2 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Product Recall, Vaccine Safety, Public Health, Infectious Disease and look for the RSS link.
StackHealth Time Machine